China Kangtai Cactus Bio-Tech Inc (fka CKGT)

[jromejwilly]

I also emailed company yesterday expressing concerns over patent issue. I received the exact same response as Steven did, but also another email from Amy at Hawk earlier the same day


Hi Jerome,
I saw those comments as well.
I will pass those comments to the management and will get back to you later.
This is what I found in the footnote of company's most recent 10Q.
"The 3 patents were created pursuant to a Research and Development Agreement entered into between the Chief Executive Officer and Director of the Company (20.5% Company Stockholder) and the General Manager and Director of the Company (18.3% Company Stockholder) and the Heilongjiang Institute of Biological Development (the “Institute”) on March 20, 2003, whereby the Institute completed the research to develop the patents and bore the costs of developing them and the aforementioned Company individuals were to register these patents and transfer their title to the Institute. That transfer took place on September 16, 2005, with no further consideration paid by the Institute. The Company purchased the 3 patents in 2010 from the Institute, a privately held Chinese entity engaged in similar ongoing patent research for other Chinese entities. The Institute has no common ownership with the Company’s Officer/Director or General Manager/Director (significant Company stockholders), or their families, or others employed by the Company or stockholders in it."
I believe this can make some clarifications.

Best regards,
Amy Lin
Associate
Hawk Associates

"Proven and Sustainable Investor Relations Strategies"
[e-mail]
Office: [phone]
Cell: [phone]
http://www.hawkassociates.com
http://www.amistockreports.com